There are currently no widely publicized or open class action lawsuits specifically related to the off-market prescribing of Alzheimer’s drugs. Off-market prescribing, often called off-label use, occurs when a medication is prescribed for a condition or in a manner not…
As of now, there is no publicly known or open class action lawsuit specifically concerning contamination in generic donepezil. Donepezil is a widely used medication primarily prescribed for the treatment of Alzheimer’s disease, and it is available both as a…
There are indeed ongoing legal actions and significant public concern regarding caregivers who feel misled by advertising related to Alzheimer’s drugs, particularly newer medications that have been promoted with claims that may not fully reflect their risks or benefits. While…
Open class actions for patients excluded from clinical trial data primarily arise when individuals believe they have been harmed by drugs or medical treatments that were approved or marketed based on incomplete or non-representative clinical trial information. These lawsuits often…
There are currently no widely publicized open class action lawsuits specifically targeting false claims about slowing Alzheimer’s progression, but the landscape of legal actions related to Alzheimer’s treatments and false advertising is evolving. While class actions over false claims in…
There is currently no widely reported or publicly known open class action lawsuit specifically targeting the cost of Aduhelm (the Alzheimer’s drug) and its impact on Medicare patients. Aduhelm, developed by Biogen, has been a subject of intense controversy due…
Open class actions related to stroke or brain bleeding after Alzheimer’s drug trials primarily focus on serious brain injuries linked to specific Alzheimer’s medications, such as Eli Lilly’s Kisunla (donanemab). Kisunla has been associated with dangerous side effects including brain…
There is currently no widely publicized or established open class action lawsuit specifically for liver damage caused by Alzheimer’s medications. While Alzheimer’s drugs, such as cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and NMDA receptor antagonists (memantine), are generally prescribed to manage…
There are currently **no widely publicized or active open class action lawsuits specifically related to long-term dependency on Aricept (donepezil)**, the medication commonly prescribed for Alzheimer’s disease. While Aricept is known to have side effects and some patients report issues…
As of now, there is a proposed class action lawsuit related to injuries caused by lecanemab infusions, but it is not yet clear if there is an officially open or widely consolidated class action. Two residents of New York have…